These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11069863)

  • 41. [Breast ductal carcinoma in situ. The clinical image in the mammogram].
    Mallek R; Mostbeck GH; Czerwenka K; Fitzal P; Wolf G
    Rofo; 1994 Jan; 160(1):30-4. PubMed ID: 8305689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surgical treatment of nonpalpable mammographic abnormalities using guidewire localization].
    Ben Aharon U; Lifscitz O; Strano SD; Mavor E; Barzilai N
    Harefuah; 1995 Feb; 128(4):205-7, 264. PubMed ID: 7744325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
    Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates.
    Blanks RG; Bennett RL; Patnick J; Cush S; Davison C; Moss SM
    Clin Radiol; 2005 Jun; 60(6):674-80. PubMed ID: 16038694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive breast cancer: mammographic measurement.
    Flanagan FL; McDermott MB; Barton PT; Pilgram TK; Dehdashti F; Wick MR; Monsees BS
    Radiology; 1996 Jun; 199(3):819-23. PubMed ID: 8638011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
    Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
    Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
    Evans A; Pinder S; Wilson R; Sibbering M; Poller D; Elston C; Ellis I
    AJR Am J Roentgenol; 1994 Jun; 162(6):1307-11. PubMed ID: 8191988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?
    Weaver DL; Vacek PM; Skelly JM; Geller BM
    Ann Surg Oncol; 2005 Aug; 12(8):660-73. PubMed ID: 15968496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammatory breast carcinoma: mammographic findings.
    Dershaw DD; Moore MP; Liberman L; Deutch BM
    Radiology; 1994 Mar; 190(3):831-4. PubMed ID: 8115635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fibroadenoma and carcinoma of the breast. Clinico-radiological considerations in 4 cases].
    Renoldi L; Recanatini L; Marzano L; Sfondrini MS; Milesi M; Landini A
    Radiol Med; 1998; 95(1-2):113-5. PubMed ID: 9636739
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical efficacy of mammographic screening in the elderly.
    Faulk RM; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    Radiology; 1995 Jan; 194(1):193-7. PubMed ID: 7997552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical case. Radiologic-pathologic correlations in breast diseases].
    Tardivon A
    J Radiol; 2002 Apr; 83(4 Pt 2):565-6. PubMed ID: 12075163
    [No Abstract]   [Full Text] [Related]  

  • 54. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overdiagnosis of breast cancer after 14 years of mammography screening.
    Zahl PH; Mæhlen J
    Tidsskr Nor Laegeforen; 2012 Feb; 132(4):414-7. PubMed ID: 22353833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Women's attitudes to false positive mammography results. A formerly clueless patient responds.
    Godby CJ
    BMJ; 2000 Dec; 321(7273):1409-10; discusson 1410-1. PubMed ID: 11187093
    [No Abstract]   [Full Text] [Related]  

  • 57. Ultrasonographic detection and characterization of asymptomatic ductal carcinoma in situ with histopathologic correlation.
    Gwak YJ; Kim HJ; Kwak JY; Lee SK; Shin KM; Lee HJ; Kim GC; Jang YJ; Han MH; Park JY; Jung JH
    Acta Radiol; 2011 May; 52(4):364-71. PubMed ID: 21498298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Radiologic analysis of known-interval cancers after 2 years of organized mass screening for breast cancer in Ille-et-Vilaine].
    de Korvin B; Courtel ML; Bohec C; Durand G; Piette C; Le Frêche JN; Duvauferrier R; Ramée A
    J Radiol; 1998 Nov; 79(11):1379-86. PubMed ID: 9846291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metachronous tumors of the breast. Mammographic findings].
    Tella S; Occhiato R; Speziale AM; Poggi R; Grasso F; Frasca F; Passariello R
    Radiol Med; 1994 Mar; 87(3):245-9. PubMed ID: 8146360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Classification of ductal carcinoma in situ by image analysis of calcifications from digital mammograms.
    Parker J; Dance DR; Davies DH; Yeoman LJ; Michell MJ; Humphreys S
    Br J Radiol; 1995 Feb; 68(806):150-9. PubMed ID: 7735745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.